↓ Skip to main content

Dermatitis herpetiformis: pathophysiology, clinical presentation, diagnosis and treatment

Overview of attention for article published in Anais Brasileiros de Dermatologia, December 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#46 of 892)
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news
1 news outlet
twitter
4 X users
patent
4 patents
facebook
4 Facebook pages
wikipedia
3 Wikipedia pages
video
1 YouTube creator

Citations

dimensions_citation
47 Dimensions

Readers on

mendeley
119 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Dermatitis herpetiformis: pathophysiology, clinical presentation, diagnosis and treatment
Published in
Anais Brasileiros de Dermatologia, December 2014
DOI 10.1590/abd1806-4841.20142966
Pubmed ID
Authors

Marcos Vinícius Clarindo, Adriana Tomazzoni Possebon, Emylle Marlene Soligo, Hirofumi Uyeda, Roseli Terezinha Ruaro, Julio Cesar Empinotti

Abstract

Researches on DH have shown that it is not just a bullous skin disease, but a cutaneous-intestinal disorder caused by hypersensitivity to gluten. Exposure to gluten is the starting point of an inflammatory cascade capable of forming autoantibodies that are brought to the skin, where they are deposited, culminating in the formation of skin lesions. These lesions are vesico-bullous, pruritic, and localized especially on elbows, knees and buttocks, although atypical presentations can occur. Immunofluorescence of perilesional area is considered the gold standard for diagnosis, but serological tests help in cases where it is negative. Patients who follow gluten-free diets have better control of symptoms on the skin and intestine, as well as lower risks of progression to lymphoma. Dapsone remains the main drug for treatment, but it requires monitoring of possible side effects, some potentially lethal.

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 119 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
Unknown 118 99%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 28 24%
Student > Master 16 13%
Student > Doctoral Student 9 8%
Student > Postgraduate 9 8%
Researcher 9 8%
Other 12 10%
Unknown 36 30%
Readers by discipline Count As %
Medicine and Dentistry 47 39%
Nursing and Health Professions 12 10%
Biochemistry, Genetics and Molecular Biology 7 6%
Agricultural and Biological Sciences 4 3%
Pharmacology, Toxicology and Pharmaceutical Science 2 2%
Other 8 7%
Unknown 39 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 20. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 September 2023.
All research outputs
#1,599,928
of 22,770,070 outputs
Outputs from Anais Brasileiros de Dermatologia
#46
of 892 outputs
Outputs of similar age
#23,649
of 361,396 outputs
Outputs of similar age from Anais Brasileiros de Dermatologia
#1
of 31 outputs
Altmetric has tracked 22,770,070 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 892 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.0. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 361,396 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 31 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.